CStone Pharmaceuticals announced the CS1002 (anti-CTLA-4 monoclonal antibody) and CS1003 (anti-PD-1 monoclonal antibody) phase Ib study data in patients with advanced solid tumors at the 2021 ESMO annual meeting
The "2020-2021 Chinese Family Standing Medicine Listed Brands" campaign is underway
Kangfang Biology initiates global phase 2 clinical treatment of atopic dermatitis with IL-4Rα monoclonal antibody
Capital scrambles to lay out, digital therapy becomes "new medical outlet"
The Phase III clinical trial of Exploratory Pharmaceuticals Proklamide for the treatment of hospitalized patients with new crown was approved by Brazil ANVISA
The results of the second phase of Hubei Province drug quality sampling inspection in 2021 announced 13 batches that did not meet the standards
Innovent and UNION therapeutics reached a strategic cooperation to introduce next-generation PDE4 inhibitors for the treatment of inflammatory skin diseases
Hengrui Medicine's "Pregabalin Sustained-Release Tablets" Approved for Listing in China
Academician Joint Laboratory Guangzhou was established to accelerate the clinical transformation of medical scientific research results in the Greater Bay Area
The completion of the acquisition of two major multinational pharmaceutical companies is related to Novartis and Boehringer Ingelheim
One-quarter of Class 1 innovative drugs come from Shanghai. Detailed explanation of the "code" for the development of Shanghai's pharmaceutical industry
The National Health Commission and other eight departments jointly issued the "Guiding Opinions on Promoting the Management of Hospital Safety and Order"
Jiangsu introduced 30 measures to promote the high-quality development of the biomedical industry
The latest release of the State Food and Drug Administration!
Uncovering the chaos in the cosmetic contact lenses industry: multiple brands use the same medical device registration number
The Nobel Prize in Physiology or Medicine is announced!
WHO launches global new crown vaccination strategy: at least 11 billion doses are needed
Innovative endoscopic weight loss technology can be expected in the future, and Tangji’s “gastric bypass stent system” has been awarded
Hebei Province Solicits Opinions on the Implementation Rules for the Management of Traditional Chinese Medicine Formula Granules
Do not wait for 1.2 million sky-high drugs
New "intestine" technology is coming?
Top 10 Space Biology Companies in the World in 2021
2022 The 19th China Nanjing Educational Equipment and Science, Education and Technology Exhibition
【Live Preview】Operation and maintenance of purified water equipment
Antiepileptic drugs can improve the cognitive function of some patients with Alzheimer's disease
Oral COVID-19 medication: effective!
The 2021 Nobel Prize in Physics announced!
New ways to prevent breast cancer
Treatment of anal cancer precursor lesions can reduce cancer risk in HIV-infected people
Difficult to choose microcrystalline cellulose?
From "buy, buy, and buy" to "sell, sell, and sell," this pharmaceutical company sold the equity of four subsidiaries during the year
In order to make the company's development strategy more focused, a pharmaceutical company cancelled another branch
39 million dollars!
Just now, the 2021 Nobel Prize in Chemistry was announced!
In order to improve the financial structure, this pharmaceutical company plans to "clear out" its core assets!
The latest study finds that targeting fatty acid synthesis pathways can effectively inhibit the new coronavirus
Stay young, start from the cell
Epigenetic therapy combined with immunotherapy to treat tumors makes a breakthrough
Research reveals new strategies for the development of antiviral drugs for RNAi inhibitors
How does the broccoli eaten in the stomach turn into anti-cancer molecules?
Kinetisol? technology broadens the preparation space and analyzes its application in the preparation of pharmaceutical amorphous solid dispersions
? Patent analysis of small molecule drug design (WuXi AppTec ddsu article)
Innovent announced the preliminary results of the Phase Ia dose escalation study of IBI315 (anti-Her2/PD-1 bispecific antibody) in patients with advanced solid tumors at the CSCO annual meeting in 2021
How to write a clinical risk management plan for CAR-T cell therapy products that meets the registration requirements
Aceclofenac of non-steroidal anti-inflammatory drugs (NSAIDs)
Medical companies join hands to carry out chip-level source innovation research
Is the target CDK2 the highest stage clinical phase III worthy of further follow-up?
Who can change the pattern of atopic dermatitis treatment?
World Alzheimer's Day: How to improve the safety, compliance and accessibility of medicines?
How does "machine learning" help new drug development?